Pharmacy Board recalls blood pressure drug, Flamodip
Health & Science
By
Esther Nyambura
| Sep 27, 2024
Due to a labeling error, the Pharmacy and Poisons Board (PPB) has recalled Flamodip tablets, manufactured by Medico Remedies.
In a statement, the Board noted that the product's labeling does not accurately reflect its content.
"The secondary packaging is labeled as Flamodip-5 (Amlodipine), while the first packaging is labeled as Flamodip-5 (Enalapril)," read the statement.
As a result, the PPB has warned the public against the use, sale, and distribution of the product.
Flamodip-5 (Amlodipine) is typically used alone or with other medications to treat high blood pressure in adults and children aged six years and older.
READ MORE
Tribunal orders KRA to refund firm Sh96.2 million
State edges KPC out of cooking gas plant deal for Nigerian firm
Money market funds book record returns on high interest rates
How connected technology, AI can help cut healthcare costs
How an education policy can safeguard your child's future
Sacco non-remittances grows as more firms face turbulence
Regional trade bloc bets on SMEs to ward off Chinese leather imports
Smelling opportunities beyond political and economic noise
KAA fetes best operators in aviation
Inflation rises to 3.6 percent in March amid higher food prices
It is also prescribed to manage certain types of angina (chest pain) and coronary artery disease, which involves the narrowing of blood vessels supplying blood to the heart.
On the other hand, Enalapril is used to treat high blood pressure and heart failure (the weakening of heart function).
Amlodipine works by relaxing blood vessels, allowing blood to flow more easily, thereby reducing blood pressure while Enalapril relaxes and widens blood vessels, helping the heart pump blood more effectively, which in turn lowers elevated blood pressure.
However, the two contain different active ingredients: Amlodipine, a calcium channel blocker, and Enalapril, an angiotensin-converting enzyme (ACE) inhibitor.